Navigation Links
JCI online early table of contents: Dec. 1, 2008
Date:12/1/2008

EDITOR'S PICK: Harnessing miRNA natural gene repressors for anticancer therapy

Michel Sadelain and colleagues, at Memorial Sloan-Kettering Cancer Center, New York, have developed a new approach to modulate the expression of genes for therapeutic purposes, and used this to mediate effective anticancer therapy in mice.

Small, noncoding RNA molecules known as miRNAs are powerful natural repressors of gene expression. In the study, the miRNA miR-181a was harnessed to segregate expression of genes in immune cells known as T cells at different stages of their development. miR-181a is highly expressed in developing T cells, in which it represses expression of many genes, and markedly downregulated in mature T cells. Sadelain and colleagues engineered mouse bone marrow cells to express therapeutic genes only when miR-181a expression is downregulated. These cells were then transplanted into mice and allowed to develop into mature T cells. Expression of the genes (and therefore the proteins made from the genes) was not detected in developing T cells, i.e., when miR-181a was highly expressed, but was detected in mature T cells, i.e., when miR-181a was downregulated. When the genes controlled by miR-181a were responsible for making proteins that target T cells to tumor cells expressing the protein hCD19, the mice that were transplanted with the engineered bone marrow cells were able to reject tumors expressing hCD19. The authors therefore suggest that it might be possible to harness miRNA-regulated therapeutic gene expression in stem cellbased therapies, including cancer immunotherapy.

TITLE: Harnessing endogenous miR-181a to segregate transgenic antigen receptor expression in developing versus post-thymic T cells in murine hematopoietic chimeras

AUTHOR CONTACT:
Michel Sadelain
Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Phone: (212) 639-6190; Fax: (917) 432-2340; E-mail: m-sadelain@ski.mskcc.org.

View the PDF of this article at: https://www.the-jci.org/article.php?id=37216


PHYSIOLOGY: The protein IRBIT helps epithelial cells secrete fluid

A number of organs, including the lung, intestine, and pancreas, have glands that secrete fluid and HCO3. Abnormal secretion of fluid and HCO3 can cause disease, including cystic fibrosis and pancreatitis. Shmuel Muallem and colleagues, at the University of Texas Southwestern Medical Center, Dallas, have provided new insight into the molecular mechanisms controlling the secretion of fluid and HCO3 by epithelial cells in the mouse pancreatic duct, data that they hope will have implications for understanding cystic fibrosis.

The authors determined that the protein IRBIT coordinates fluid and HCO3 secretion by epithelial cells in the mouse pancreatic duct through its ability to activate two proteins (pNBC1 and CFTR) that are components of different cell surface complexes involved in the transport of HCO3 into and out of epithelial cells. Activation of pNBC1 is required for HCO3 entry into epithelial cells at the basolateral surface and activation of CFTR is required for HCO3 secretion from epithelial cells at the luminal surface. Further analysis revealed that IRBIT seems to activate these two proteins by distinct mechanisms and that it regulates CFTR by reducing the amount of time the channel is closed. Thus, IRBIT is a key coordinator of a central function of epithelial cells expressing CFTR, the protein that is defective in individuals with cystic fibrosis.

TITLE: IRBIT coordinates epithelial fluid and HCO3 secretion by stimulating the transporters pNBC1 and CFTR in the murine pancreatic duct

AUTHOR CONTACT:
Shmuel Muallem
University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Phone: (214) 645-6008; Fax: (214) 645-6049; E-mail: shmuel.muallem@utsouthwestern.edu.

View the PDF of this article at: https://www.the-jci.org/article.php?id=36983


PHYSIOLOGY: Lactoferrin explains why apoptotic cell death isn't inflammatory

Cells can die in a number of different ways, including by a form of programmed cell death known as apoptosis. One important aspect of apoptosis is that it does not trigger inflammation. This is in part because the dead cells are rapidly cleared away by cells known as mononuclear phagocytes, rather than phagocytes that are associated with inflammatory responses. Christopher Gregory and colleagues, at Edinburgh University, United Kingdom, have now identified a molecular mechanism that explains why apoptotic cells are cleared away by mononuclear phagocytes, rather than phagocytes associated with inflammatory responses.

In the study, in vitro analysis indicated that numerous apoptotic human cell lines release a soluble factor known lactoferrin, which has previously been shown to have anti-inflammatory properties. Further in vitro analysis revealed that lactoferrin inhibited the migration of phagocytes associated with inflammatory responses but not the migration of mononuclear phagocytes. Similar results were obtained in mice. The authors therefore conclude that lactoferrin has a key role in ensuring that apoptotic cell death is a form of cell death not associated with inflammation through its ability to inhibit the recruitment of phagocytes associated with inflammatory responses.

TITLE: Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin

AUTHOR CONTACT:
Christopher D. Gregory
The University of Edinburgh, Edinburgh, United Kingdom.
Phone: 44-131-242-9170; Fax: 44-131-242-9171; E-mail: chris.gregory@ed.ac.uk.

View the PDF of this article at: https://www.the-jci.org/article.php?id=36226


'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Related medicine news :

1. HIV denialists spread misinformation online -- consequences could be deadly; and more
2. Consequences of online HIV denial; and more
3. Online Epidemic Gives Clues to Bird Flu Spread
4. MedHelp to Add Top Stanford Surgeons and Specialized Forums to Online Health Community
5. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
6. Syndicom to Launch Online Community for DePuy Spine
7. Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community
8. Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. Dynamic Energy Systems Goes Online and On-Demand
11. North Shore-LIJ Health System Begins Online Posting of Hospital Infection Rates, Other Performance Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
(Date:6/23/2016)... NORTHBROOK, Ill. and BOGOTA, Colombia , June 23, 2016  Astellas today announced the ... joins Astellas Farma Brasil as the company,s second affiliate in Latin America . ... ... appointed General Manager of Astellas Farma Colombia ... ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology: